about
Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase.Endocrine Tumors Causing Arterial Hypertension: Pathophysiological Mechanisms and Clinical Implications.Impact of left ventricular remodeling and renal function on 24h-ECG recordings and cardiovascular outcome in elderly hypertensive patients.Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia.Mean Transaortic Gradient is an Emerging Predictor of Chronic Kidney Disease in Elderly Patients.Comparison of Wells and Revised Geneva Rule to Assess Pretest Probability of Pulmonary Embolism in High-Risk Hospitalized Elderly Adults.Norepinephrine, left ventricular disorders and volume excess in ESRD.Testing Clinical Scores to Diagnose Incident Deep Vein Thrombosis in Patients Hospitalized in a Department of Medicine: Can Biomarkers Improve Accuracy?Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease.Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension. Salt Sensitivity Group of Italian Society of Hypertension.Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.The prevalence of the cardiac origin of chest pain: the experience of a rural area of southeast Italy.Prognostic value of echocardiographic indicators of left ventricular systolic function in asymptomatic dialysis patients.Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression.Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients.Conceptual basis and methodology of the SOPHIA study.Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.Diagnostic potential of cardiac natriuretic peptides in dialysis patients.Circulating E-selectin as a risk marker in patients with end-stage renal disease.Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.Hepatocyte Growth Factor and Cardiomyopathy in Dialysis PatientsNeuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patientsSoluble E-Selectin Is an Inverse and Independent Predictor of Left Ventricular Wall Thickness in End-Stage Renal Disease PatientsFibrinogen, mortality and incident cardiovascular complications in end-stage renal failureHepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal DiseaseDiagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patientsTroponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patientsPulse Pressure Is an Independent Predictor of Aortic Stiffness in Patients with Mild to Moderate Chronic Kidney DiseaseBleeding of Small Bowel in Henoch-Schönlein Syndrome: The Successful Diagnostic Role of Video Capsule EndoscopyExtension of a Pelvic Tumor into the Right AtriumRelease of immunoreactive endothelin from the heart during percutaneous transluminal coronary angioplastyTransient myocardial ischemia stimulates atrial natriuretic factor releaseBaseline and post-atrial pacing release of atrial natriuretic factor in mitral stenosisComparison of ketanserin and enalapril in the treatment of mild-to-moderate essential hypertension
P50
Q35737993-09E061D1-709A-4D43-A6AA-ACC9A1EB637FQ39239777-E532558D-5AF3-4BD3-9DB7-A219307CCE88Q40092865-C29BF1FD-6946-4FB0-B70C-1A5C158701D9Q40243653-A37481C0-DCB3-492C-8FBE-05F3CF0737D2Q40489321-AF8B0C40-10AF-47A8-A993-4C0184030C25Q40880721-F655D426-D0A5-48CA-A8C8-8843C2D79AC2Q41362264-21A6E218-843A-43B0-94A2-63EDF2054112Q41727603-221A6305-3E67-4843-BB75-4F47DBD7D6D8Q42931744-9FF14969-5349-4587-BA79-998BC232C3CDQ43561436-21A5B72A-A326-47E0-8438-952FB5C0F466Q43921904-133810A0-BA08-480E-AAD5-1D8AAD0811EFQ44342805-B98E9195-1742-42EF-AB7D-B8FE688EABE6Q44416974-78EA1AC1-1345-4AAB-BABB-8A9E3ACC65F7Q44846006-1669F103-C411-441B-9814-8C7CB7F4A008Q46433233-EDB779A8-9784-4949-9114-93015C81163EQ46885454-9340BA47-E9B8-40DC-80BD-2504CE026037Q48715520-D820CB2B-7D1C-48EF-B866-A949C258EAD0Q48945446-FF809F22-888C-4118-9ADE-D95E6AFD4BE7Q53527306-AD548D8D-A740-4D53-9EAA-5F1D88BB6661Q55070146-FCB4C62F-BDE2-48CE-92FC-4C7B53DEDD95Q58946710-C65FF9C6-DAE0-4CBC-95F2-0E902AE137AEQ58947980-7AD1964A-9960-49DF-87E2-C553CAB6BD26Q58948069-9E6461CA-F7C6-4FFE-B6CE-EAF98A25687EQ58950361-179AB5AC-2051-49A6-A0FB-3A7B8EF64DF0Q58950388-73F674DA-E9FF-40EA-9630-15219B005A8CQ58950532-B39E5181-9DEF-4B4D-BC0E-7E4FAE49AAC4Q58950712-74D69C0B-07F0-4D54-8888-BA9571484F7AQ63435865-85701180-EEB5-4E1A-A324-AA65FDECCF99Q63435868-B10385E3-017E-4498-B7C3-C7C36520877FQ63435876-AE4B2663-E606-4F61-AE31-B2CD69DBAF3BQ63435877-431864AF-F6D7-4343-A2AB-9706658775F2Q63435878-D9E61EA3-D77F-4DB9-A3EB-D13661C54959Q63435880-65F4C1FF-FBCC-466D-8E84-7EB7EC83F3F2Q63435881-30A49BC3-D381-427C-A018-ACEF5478B5F9
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Benedetta Stancanelli
@ast
Benedetta Stancanelli
@en
Benedetta Stancanelli
@es
Benedetta Stancanelli
@nl
Benedetta Stancanelli
@sl
type
label
Benedetta Stancanelli
@ast
Benedetta Stancanelli
@en
Benedetta Stancanelli
@es
Benedetta Stancanelli
@nl
Benedetta Stancanelli
@sl
prefLabel
Benedetta Stancanelli
@ast
Benedetta Stancanelli
@en
Benedetta Stancanelli
@es
Benedetta Stancanelli
@nl
Benedetta Stancanelli
@sl
P106
P1153
6602827635
P21
P31
P496
0000-0001-8340-6185